IntelGenx is a leading drug delivery company focused on the development of innovative products based on its proprietary oral drug delivery technologies. Established in , the Montreal based company develops innovative oral drug delivery solutions based on its proprietary platform technologies, VersaFilmTM, VersaTabTM and AdVersaTM. IntelGenx has developed a broad and diverse product portfolio addressing unmet market needs and offering lifecycle management opportunities. Forfivo XLTM, launched in , is the first and only FDA approved once daily bupropion HCl mg dose in a single tablet for the treatment of major depressive disorder. IntelGenx highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R amp D, clinical monitoring, IP protection, analytical method development and regulatory services. IntelGenx state of the art manufacturing facility, established for the VersaFilmTM technology platform, supports lab scale to pilot and commercial scale production, offering full service capabilities to our clients. IntelGenx Technologies Corp. is listed on the TSX V and OTC QX, More information is available about the company at: www.intelgenx.com.
Quote | Intelgenx Techs Corp (OTCMKTS:IGXT)
Last: | $0.165 |
---|---|
Change Percent: | 8.82% |
Open: | $0.155 |
Close: | $0.165 |
High: | $0.17025 |
Low: | $0.155 |
Volume: | 53,282 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Intelgenx Techs Corp (OTCMKTS:IGXT)
SAINT LAURENT, Quebec, April 08, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that Montelukast VersaFilm ® has been administered to the first Parkinson’s Disease (“PD”) patients in the Phase 2 (...
SAINT LAURENT, Quebec, April 05, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC (“Xiromed”), has receive...
Message Board Posts | Intelgenx Techs Corp (OTCMKTS:IGXT)
Subject | By | Source | When |
---|---|---|---|
$IGXT The now | SurgeGuy2.0 | investorshub | 05/13/2023 8:47:53 AM |
$IGXT When is this gonna take off? | SurgeGuy2.0 | investorshub | 05/04/2023 6:25:58 AM |
$IGXT Do we have a winner?Turn around time? | SurgeGuy2.0 | investorshub | 05/03/2023 1:07:00 PM |
$IGXT Good news recently, we should start to see this one move | Tasso9 | investorshub | 05/02/2023 6:41:40 AM |
Price gaining | SurgeGuy2.0 | investorshub | 05/01/2023 1:05:54 PM |
News, Short Squeeze, Breakout and More Instantly...
Intelgenx Techs Corp Company Name:
IGXT Stock Symbol:
OTCMKTS Market:
SAINT LAURENT, Quebec, April 08, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that Montelukast VersaFilm ® has been administered to the first Parkinson’s Disease (“PD”) patients in the Phase 2 (...
SAINT LAURENT, Quebec, April 05, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC (“Xiromed”), has receive...
SAINT LAURENT, Quebec, March 21, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "Int...